Holen Sie sich die Stockscreener-App
1.42
5.96%
-0.09
Handel nachbörslich:
1.49
0.07
+4.93%
Schlusskurs vom Vortag:
$1.51
Offen:
$1.5
24-Stunden-Volumen:
41,147
Relative Volume:
0.42
Marktkapitalisierung:
$75.24M
Einnahmen:
$63.69M
Nettoeinkommen (Verlust:
$-44.82M
KGV:
-0.71
EPS:
-2
Netto-Cashflow:
$-30.56M
1W Leistung:
-10.13%
1M Leistung:
-21.98%
6M Leistung:
-31.73%
1J Leistung:
-45.17%
1-Tages-Spanne:
$1.42
$1.50
1-Wochen-Bereich:
$1.42
$1.64
52-Wochen-Spanne:
$1.35
$3.50
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MDXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
1.42 | 75.24M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
497.60 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.00 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
419.95 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.98 | 33.45B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
176.30 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-31 | Eingeleitet | Lake Street | Buy |
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
Bleichroeder LP's Strategic Acquisition of MDxHealth SA Shares - GuruFocus
MDxHealth SA (NASDAQ:MDXH) Short Interest Up 133.8% in February - Defense World
MDxHealth CEO acquires company shares worth $80,000 By Investing.com - Investing.com Australia
MDxHealth stock hits 52-week low at $1.49 amid market challenges - Investing.com Canada
MDxHealth stock hits 52-week low at $1.49 amid market challenges By Investing.com - Investing.com South Africa
MDxHealth CEO acquires company shares worth $80,000 - Investing.com India
Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH) - Yahoo Finance
Research Analysts Issue Forecasts for MDxHealth Q1 Earnings - Defense World
What is William Blair’s Forecast for MDxHealth Q1 Earnings? - Defense World
MDxHealth SA (MDXH) Reports Q4 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Call Transcript - MSN
Mdxhealth S.A. Reports Strong Revenue Growth in Earnings Call - TipRanks
MDxHealth (NASDAQ:MDXH) Issues Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Q4 2024 Earnings Call Transcript - Insider Monkey
Mdxhealth fourth quarter revenue grows 28% to USD 24.7M - Medical Buyer
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results - The Manila Times
MDxHealth SA (MDXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges - Yahoo Finance
MDxHealth ADR earnings beat by $0.05, revenue topped estimates - Investing.com South Africa
MDxHealth SA reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: MDxHealth beats Q4 2024 EPS forecast, stock rises - Investing.com
Earnings Flash (MDXH) MDxHealth SA Reports Q4 Revenue $24.7M, vs. FactSet Est of $23.3M - Marketscreener.com
Can MDxHealth's 28% Revenue Growth Finally Deliver Profitability in 2025? - StockTitan
MDxHealth SA expected to post a loss of 19 cents a shareEarnings Preview - TradingView
MDxHealth (MDXH) Projected to Post Earnings on Wednesday - Defense World
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26 - The Manila Times
MDxHealth Earnings Alert: Key Financial Results & Strategic Updates Unveiled Next Week - Stock Titan
MDxHealth's study on assureMDx published in Journal of Urology - Reuters.com
MDxHealth SA Provides Revenue Guidance for the Fourth Quarter of 2024, Full Year of 2024 and Year 2025 - Marketscreener.com
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance - The Manila Times
MDxHealth Reports Strong 28% Revenue Growth, Projects EBITDA Profitability in 2025 - StockTitan
Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World
Critical Survey: BioNexus Gene Lab (NASDAQ:BGLC) versus MDxHealth (NASDAQ:MDXH) - Defense World
MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics (NASDAQ:MDXH) - Seeking Alpha
MDxHealth (STU:O6C1) Enterprise Value : €88.51 Mil (As of Dec. 08, 2024) - GuruFocus.com
MDxHealth (CHIX:MDXHB) Enterprise Value : €102.00 Mil (As of Dec. 01, 2024) - GuruFocus.com
MDxHealth to Participate in Piper Sandler Healthcare Conference - The Manila Times
MDxHealth CEO to Present at Piper Sandler Healthcare Conference in NYC | MDXH Stock News - StockTitan
OneDigital Investment Advisors LLC Increases Stock Position in MDxHealth SA (NASDAQ:MDXH) - Defense World
MVM Partners, LLC Reduces Stake in Paragon 28 Inc - GuruFocus.com
MDxHealth SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MDxHealth stock hits 52-week low at $1.57 amid market challenges By Investing.com - Investing.com South Africa
MDxHealth stock hits 52-week low at $1.57 amid market challenges - Investing.com
OC500 2024: Michael McGarrity - Orange County Business Journal
AWM Investment Company's Strategic Acquisition of MDxHealth SA S - GuruFocus.com
MDxHealth stock hits 52-week low at $1.93 amid market challenges - Investing.com
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
1.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):